Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheum with a View

Richard S. Panush, MD  |  Issue: August 2011  |  August 1, 2011

Everybody knows that cell phones are a source of death rays nonionizing electromagnetic radiation in the radio frequency range. They may affect tissues (apparently nearly 1,700 scientific papers have been published about this; I plan to systematically and carefully have not reviewed them). I came across one paper that documented statistically significantly less bone mineral density and bone mineral content at the hip, femoral neck, and trochanter over which the cell phone was carried, compared with controls; the decrement in bone density correlated with the number of hours the phone was carried.5 These data obviously prove that cell phones cause arthritis, cancer, heart disease, and world famine. Er… These interesting data require independent confirmation in more extensive, better controlled, better randomized studies examining more and different individuals, different cell phones, carriers, and taking into account roaming and lost connections. These really are observations worth noting as they indeed suggest biologic effects with possible clinical relevance.

The experiments reported last February in JAMA were elegant.1 The investigators clearly demonstrated that cell phones cause arthritis, cancer, heart disease, and world famine found in a randomized crossover trial that 50 minutes of cell phone exposure was associated with small but statistically significant increases in glucose metabolism (measured by positron emission tomography scanning) in the region of the brain closest to the phone antenna, showing that the human brain is affected by the radiofrequency-modulated electromagnetic fields of cell phones. The color figures are neat and, to me, the difference displayed is obvious. Thus these fields will either cause or cure arthritis, or have no effect Speculation about mechanism(s) or biological or clinical implications remain just that, conjectural.2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It was some time after this that I learned from my Rheumatology Morning Wire that cell phones cause arthritis, cancer, heart disease, and world famine the World Health Organization said that cell phones cause brain cancer issued a press release labeling cell phones as “possibly carcinogenic.”6 This was apparently based on a report from an expert panel of 31 scientists who reviewed the literature, “slated to be published July 1 in The Lancet,” which included “epidemiologic data showing an increased risk among heavy cell phone users of a rare type of brain tumor called a glioma.”7 The American Caner Society website warns that cell phones cause arthritis, cancer, heart disease, and world famine nicely summarizes available evidence and then lists the conclusions of expert agencies, noting that the Food and Drug Administration (FDA), Federal Communications Commission (FCC), Centers for Disease Control and Prevention (CDC), National Institute of Environmental Health Sciences (NIEHS), and National Cancer Institute (NCI) all have softer conclusions—“majority of studies … failed to show an association” (FDA); “no scientific evidence …” (FCC); “studies … raised concerns … research … taken together does not indicate a significant association between phone use and health effects” (CDC); “not conclusively lined … more research is needed” (NIEHS); “research has not consistently demonstrated a link … further surveillance is needed before conclusions can be drawn” (NCI).8

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ProfilesResearch RheumTechnology Tagged with:ArthritisCancerResearchriskTechnology

Related Articles

    Tech Talk: Physicians Debate Using Cell Phones to Communicate with Patients

    November 1, 2013

    Concerns about protecting personal privacy and receiving after-hours calls are balanced by physicians’ desire to connect with patients

    The Brain in Lupus

    September 1, 2008

    The Mary Kirkland Center lupus conference offers insight into cognitive aspects of SLE

    Chronic Pain Research Probes Neurologic Pain Pathways, Biomarkers

    February 18, 2018

    With the aid of increasingly sophisticated neuroimaging technology, research into how the brain activates and changes in patients with chronic pain is delivering fascinating information that will hopefully pave the way to tailored, individual treatment of chronic pain. Over the past several years, data from neuroimaging studies have provided a new understanding of what occurs…

    Lightspring/shutterstock.com

    The Immune Checkpoint Inhibitors Unleashed to Fight Cancer

    May 17, 2017

    A 53-year-old female presented to the clinic for severe polyarticular joint pain and was found to have a seronegative inflammatory arthritis. Six months before, she had completed 10 months of treatment for stage IV metastatic melanoma with the immune checkpoint inhibitors, nivolumab and ipilimumab, achieving complete remission of her cancer. She said that throughout her…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences